Genomic data with clinical outcome data from routine practice data from The University of Texas MD Anderson Cancer Center, Houston, TX, USA
The Clinical Cancer Genetics Program can coordinate genetic testing and high-risk cancer surveillance for individuals and their families with hereditary cancer syndromes. Genetic testing can help determine whether a family has a hereditary cancer predisposition syndrome. Individuals who have genetically higher risks to develop certain cancers are recommended to follow high-risk cancer surveillance and management.
- Study design
- Patients' cohort
- Sources of Recruitment
Number of participants
- Number of participants
- Number of participants with biosamples
Availability of data and biosamples
No coverage data about the variables classifications are available.